Cite
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer
MLA
Urba, W. J., et al. Immunomodulatory Properties and Toxicity of Interleukin 2 in Patients with Cancer. Jan. 1990. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3657..b4e3df9174486f9c83fb3aa97eea64a5&authtype=sso&custid=ns315887.
APA
Urba, W. J., Steis, R. G., Longo, D. L., Kopp, W. C., Maluish, A. E., Marcon, L., Nelson, D. L., Stevenson, H. C., & Clark, J. W. (1990). Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.
Chicago
Urba, W. J., R. G. Steis, D. L. Longo, W. C. Kopp, A. E. Maluish, Luisa Marcon, D. L. Nelson, H. C. Stevenson, and J. W. Clark. 1990. “Immunomodulatory Properties and Toxicity of Interleukin 2 in Patients with Cancer,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3657..b4e3df9174486f9c83fb3aa97eea64a5&authtype=sso&custid=ns315887.